MedPath

CT-P63

Generic Name
CT-P63

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

Phase 1
Completed
Conditions
SARS-CoV-2 Infection
Interventions
Drug: Placebo
First Posted Date
2021-08-23
Last Posted Date
2022-08-11
Lead Sponsor
Celltrion
Target Recruit Count
24
Registration Number
NCT05017168
Locations
🇵🇱

Biokinetica S.A, Józefów, Poland

© Copyright 2025. All Rights Reserved by MedPath